APA (7th ed.) Citation

K, N., X, B., K, O., S, Z., Y, Z., RI, C., . . . JR, W. (2026). Corrigendum to "Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma" [Cancer Lett. 449 (2019) 87-98]. Cancer letters, 637, 218118. https://doi.org/10.1016/j.canlet.2025.218118

Chicago Style (17th ed.) Citation

K, Nagaoka, et al. "Corrigendum to "Anti-tumor Activity of Antibody Drug Conjugate Targeting Aspartate-β-hydroxylase in Pancreatic Ductal Adenocarcinoma" [Cancer Lett. 449 (2019) 87-98]." Cancer Letters 637 (2026): 218118. https://doi.org/10.1016/j.canlet.2025.218118.

MLA (9th ed.) Citation

K, Nagaoka, et al. "Corrigendum to "Anti-tumor Activity of Antibody Drug Conjugate Targeting Aspartate-β-hydroxylase in Pancreatic Ductal Adenocarcinoma" [Cancer Lett. 449 (2019) 87-98]." Cancer Letters, vol. 637, 2026, p. 218118, https://doi.org/10.1016/j.canlet.2025.218118.